On Friday, Shares of Yingli Green Energy Hold. Co. Ltd. (ADR)(NYSE:YGE), lost -0.98% to $1.01.
Yingli Green Energy, declared that it plans to release its unaudited financial results for the quarter ended March 31, 2015, before the U.S. market opens on Friday, June 5, 2015.
The Company has planned a corresponding conference call and live webcast to talk about the results at 8:00 AM U.S. Eastern Daylight Time on June 5, 2015, which corresponds to 8:00 PM Beijing/Hong Kong time on the same day.
Yingli Green Energy Holding Company Limited, together with its auxiliaries, designs, develops, markets, manufactures, sells, and installs photovoltaic products in the Peoples Republic of China and internationally.
Shares of Lockheed Martin Corporation (NYSE:LMT), declined -1.01% to $ 188.20, during its last trading session.
Lockheed Martin has assembled NASA’s InSight Mars spacecraft, which is now undergoing environmental testing at the company’s Space Systems facilities near Denver. InSight is NASA’s next mission to Mars and will be the first mission devoted to understanding the interior structure of the planet.
InSight will endure the extreme vibration and noise of launch, a long journey through the vacuum and cold of deep space and the gauntlet of entry through the Martian atmosphere before startning operations on the surface. Because of the extreme environments the spacecraft will encounter during its mission, the lander will undergo a variety of rigorous tests that will ensure it can survive the journey.
Lockheed Martin Corporation, a security and aerospace company, engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services.
At the end of Friday’s trade, Shares of NeoStem Inc (NASDAQ:NBS), gained 3.40% to $ 2.13.
NeoStem, declared plans to change its corporate name to Caladrius Biosciences, effective June 8, 2015.
“The forthcoming name change and rebranding of NeoStem are important steps to outwardly reflect what those in the industry and our clients already know about the company — that we are a leader in the innovation, development and manufacture of cell-based individualized medicine and immuno-oncology, with extensive experience in dozens of cell types in addition to a pipeline using many cells of the immune system beyond stem cells,” said Dr. David J. Mazzo, Chief Executive Officer of NeoStem. “The new corporate name reflects the company’s integrated approach to cell therapy and creates a foundation for better market understanding of our position in the field.”
NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States.
Finally, Nordstrom, Inc. (NYSE:JWN), ended its last trade with -1.34% loss, and close at $ 72.64.
Nordstrom, declared a contract under which TD will acquire Nordstrom’s existing U.S. Visa and private label consumer credit card portfolio, which presently totals about $2.2 billion in receivables. In addition, the two companies have reached a separate long-term agreement under which TD will become the exclusive U.S. issuer of Nordstrom-branded Visa and private label consumer credit cards to Nordstrom customers.
This transaction enables Nordstrom to retain all aspects of customer-facing activities, aligning with Nordstrom’s strategy of enhancing the customer experience while allowing for improvement in capital efficiency.
Nordstrom, Inc., a fashion specialty retailer, offers apparel, shoes, cosmetics, and accessories for men, women, and children in the United States and Canada. It operates through two segments, Retail and Credit.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
